EULAR 2019 | Preview
The Annual Scientific European Congress of Rheumatology (EULAR) will take place in Madrid, Spain, from the 12th to 15th June 2019.
Amongst the array of sessions are included: ‘Psoriatic arthritis: old and new drugs and how to deal with them’, ‘Different pathophysiological pathways in axial and peripheral disease: Peripheral and axial spondyloarthritis: to split or to lump?’, ‘Difficult to manage Sjogren’s Syndrome and Myositis’, ‘EULAR projects in clinical affairs’.
Further details from the European Congress of Rheumatology 2019 can be found here.
Visit our sponsored learning zone for Psoriasis – featuring video discussions from Paolo Gisondi and Rolland Gyulai highlighting the prevalence, unmet needs, comorbidities, treatment goal and treatment options of psoriasis. A multidisciplinary approach for psoriasis management has been recommended by EULAR since 2012. Treatments include certolizumab pegol and biologic treatments for psoriasis in clinical development including JAK inhibitors: tofacitinib, baricitinib and peficitinib.